Bluejay Diagnostics (BJDX) Shares Outstanding (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Shares Outstanding (Entity) of $1.0 million for Q1 2026, up 130.43% sequentially from $449043.0 in Q4 2025, and up 647.07% YoY from $138503.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Shares Outstanding (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 647.07% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 647.07% YoY) and the FY2025 annual result came in at $449043.0, up 879.42% from the prior year.
- Shares Outstanding (Entity) climbed to $1.0 million in Q1 2026 per BJDX's latest filing, from $449043.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $1.0 million in Q1 2026 and troughed at $630.0 in Q1 2022.
- A 5-year average of $147568.4 and a median of $1680.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) increased 1.43% in 2023, then jumped 15361.34% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $632.0 in 2022, then advanced by 22.47% to $774.0 in 2023, then soared by 5823.51% to $45848.0 in 2024, then soared by 879.42% to $449043.0 in 2025, then soared by 130.43% to $1.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.0 million, $449043.0, and $409783.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Bluejay Diagnostics | 1.92 Mn | 1.92 Mn | - | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 984,668.00 |
| Mar 31, 2026 | 984,668.00 |
| Dec 31, 2025 | 449,043.00 |
| Sep 30, 2025 | 393,634.00 |
| Jun 30, 2025 | 346,780.00 |
| Mar 31, 2025 | 138,503.00 |
| Dec 31, 2024 | 45,848.00 |
| Sep 30, 2024 | 47,779.00 |
| Jun 30, 2024 | 2,416.00 |
| Mar 31, 2024 | 1,475.00 |
| Dec 31, 2023 | 685.00 |
| Sep 30, 2023 | 689.00 |
| Jun 30, 2023 | 639.00 |
| Mar 31, 2023 | 637.00 |
| Dec 31, 2022 | 630.00 |
| Sep 30, 2022 | 630.00 |
| Jun 30, 2022 | 630.00 |
| Mar 31, 2022 | 629.00 |
| Dec 31, 2021 | 266.00 |
| Sep 30, 2021 | 328.00 |